Composition with topical anaesthetic effect and the use thereof
EP3400949A1
Composition for topical use, in particular for bladder instillation
EP3400951A1
Bladder instillation composition containing chondoitin sulfate (4,5 mg/ml), hyaluronic acid (16 mg/ml) and phosphate buffer (ph 6,1 to 7,9) with an improved storage stability for the treatment of cystitis
EP3400950A1
Bladder instillation composition containing chondoitin sulfate (20 mg/ml), hyaluronic acid (16 mg/ml) and phosphate buffer (ph 6,1 to 7,9) with an improved storage stability for the treatment of cystitis
DE102017105010A1
Composition, in particular gel, for use in the genitourinary tract
DE102016119183A1
Medical composition, in particular in the form of a medicinal gel, and its use
DE102014100274A1
Composition, in particular in the form of a gel, and its use
DE102011102974A1
Topical rectal application set useful for delivering local anesthetic and/or disinfecting agent during prostate biopsy, comprises rectal applicator containing local anesthetic and/or disinfecting agent, and application device
DE102011101091A1
penis terminal
DE102007003765A1
Pharmaceutical composition for the treatment of incontinence
DE102006062111A1
Composition, in particular for blocking catheters
DE102006060953A1
Synergistic preparation for treating urinary tract inflammation, e.g. cystitis, contains low molecular hyaluronic acid and another glycosaminoglycan, preferably chondroitin sulfate
DE102005062159A1
Analytical unit for detecting interaction between target and capture molecules, useful for detecting cancers and inflammation of the urinary tract
EP0703793A1
Process for producing sterile packings of ready-for-use articles and container for such packings
DE3506873A1
SYSTEM FOR COLLECTING FRAGRANCES THAT ARRIVE IN THE CRUSHING OF STONES IN BODIES OF LIVING PEOPLE AND WARM BLOOMED ANIMALS
DE3441502A1
Pharmaceutical preparation for the prophylaxis of calcium oxalate stones
